Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type Exenatide, is a medication used to treat diabetes mellitus type 2. Note: (see Drugs@FDA for complete indication)<\/p>\n
What is BYETTA? \u2022 BYETTA is an injectable prescription medicine that may improve blood sugar (glucose) control in adults with type 2 diabetes mellitus, when used with a diet and exercise program. \u2022 BYETTA is not insulin. \u2022 You should not take BYETTA instead of insulin. \u2022 The use of BYETTA with insulin is not recommended. \u2022 BYETTA is not for people with type 1 diabetes or people with diabetic ketoacidosis. \u2022 It is not known if BYETTA is safe and effective in children. \u2022 BYETTA has not been studied in people who have pancreatitis. \u2022 BYETTA should not be used in people who have severe kidney problems.\u00a0 Active Ingredient: exenatide Inactive Ingredients: metacresol, mannitol, glacial acetic acid, and sodium acetate trihydrate in water for injection.<\/p>\n
BYETTA (exenatide) Injection Initial U.S. Approval: 2005
\nTo access exenatide Injection sold under the brand name can be made available on request to patient if the drug has not been approved or is not available in your country. For information or advice, call IPN’s Pharmaceutical Expert. Our expert will be happy to take your query and guide with an effective solution. Be free and call today for full support at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj)<\/p>\n","protected":false},"excerpt":{"rendered":"
BYETTA is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.<\/p>\n
Facts about exenatide Injection\u00a0<\/strong><\/p>\n Approval Date: \u00a02005 If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cExenatide Injection\u201d based on the information you provide.<\/strong><\/p>\n
\nProprietary Name: \u00a0BYETTA (exenatide) Injection
\nActive Ingredient(s): \u00a0exenatide
\nFDA-approved use: 2 diabetes mellitus.
\nDosage Form: \u00a0BYETTA is supplied as 250 mcg\/mL exenatide in:\u00a0 \u2022 5 mcg per dose, 60 doses, 1.2 mL prefilled pen \u2022 10 mcg per dose, 60 doses, 2.4 mL prefilled pen.
\nMedicine Approved By: Food and Drug Administration (FDA)
\nManufacturer: Amylin Pharmaceuticals, Inc.
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n